Global Acute Intermittent Porphyria Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

November 2018 | 116 pages | ID: G4A3A7BC8A8EN
GlobalInfoResearch

Abstracts

Acute intermittent porphyria (AIP) is a genetic metabolic disorder affecting the production of heme, the oxygen-binding prosthetic group of hemoglobin. It is characterized by a deficiency of the enzyme porphobilinogen deaminase.

Scope of the Report:

The worldwide market for Acute Intermittent Porphyria is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Acute Intermittent Porphyria in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

• Dahaner
• Roche
• Bio-Rad Laboratories
• Siemens
• ARKRAY
• Sysmex Corporation
• ACON Laboratories

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Gonadotropin-Releasing Hormone Analogues
• Prophylactic Hematin Infusions

Market Segment by Applications, can be divided into

• Hospitals & Clinics
• Research Centers

There are 15 Chapters to deeply display the global Acute Intermittent Porphyria market.

Chapter 1, to describe Acute Intermittent Porphyria Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Acute Intermittent Porphyria, with sales, revenue, and price of Acute Intermittent Porphyria, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Acute Intermittent Porphyria, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Acute Intermittent Porphyria market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Acute Intermittent Porphyria sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Acute Intermittent Porphyria Introduction
1.2 Market Analysis by Type
  1.2.1 Gonadotropin-Releasing Hormone Analogues
  1.2.2 Prophylactic Hematin Infusions
1.3 Market Analysis by Applications
  1.3.1 Hospitals & Clinics
  1.3.2 Research Centers
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Dahaner
  2.1.1 Business Overview
  2.1.2 Acute Intermittent Porphyria Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Dahaner Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche
  2.2.1 Business Overview
  2.2.2 Acute Intermittent Porphyria Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Roche Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bio-Rad Laboratories
  2.3.1 Business Overview
  2.3.2 Acute Intermittent Porphyria Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Bio-Rad Laboratories Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Siemens
  2.4.1 Business Overview
  2.4.2 Acute Intermittent Porphyria Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Siemens Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 ARKRAY
  2.5.1 Business Overview
  2.5.2 Acute Intermittent Porphyria Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 ARKRAY Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sysmex Corporation
  2.6.1 Business Overview
  2.6.2 Acute Intermittent Porphyria Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Sysmex Corporation Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 ACON Laboratories
  2.7.1 Business Overview
  2.7.2 Acute Intermittent Porphyria Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 ACON Laboratories Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL ACUTE INTERMITTENT PORPHYRIA SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)

3.1 Global Acute Intermittent Porphyria Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Acute Intermittent Porphyria Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
  3.3.1 Top 3 Acute Intermittent Porphyria Manufacturer Market Share in 2017
  3.3.2 Top 6 Acute Intermittent Porphyria Manufacturer Market Share in 2017
3.4 Market Competition Trend

4 GLOBAL ACUTE INTERMITTENT PORPHYRIA MARKET ANALYSIS BY REGIONS

4.1 Global Acute Intermittent Porphyria Sales, Revenue and Market Share by Regions
  4.1.1 Global Acute Intermittent Porphyria Sales and Market Share by Regions (2013-2018)
  4.1.2 Global Acute Intermittent Porphyria Revenue and Market Share by Regions (2013-2018)
4.2 North America Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
4.3 Europe Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
4.5 South America Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

5 NORTH AMERICA ACUTE INTERMITTENT PORPHYRIA BY COUNTRIES

5.1 North America Acute Intermittent Porphyria Sales, Revenue and Market Share by Countries
  5.1.1 North America Acute Intermittent Porphyria Sales and Market Share by Countries (2013-2018)
  5.1.2 North America Acute Intermittent Porphyria Revenue and Market Share by Countries (2013-2018)
5.2 United States Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
5.3 Canada Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
5.4 Mexico Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

6 EUROPE ACUTE INTERMITTENT PORPHYRIA BY COUNTRIES

6.1 Europe Acute Intermittent Porphyria Sales, Revenue and Market Share by Countries
  6.1.1 Europe Acute Intermittent Porphyria Sales and Market Share by Countries (2013-2018)
  6.1.2 Europe Acute Intermittent Porphyria Revenue and Market Share by Countries (2013-2018)
6.2 Germany Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
6.3 UK Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
6.4 France Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
6.5 Russia Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
6.6 Italy Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

7 ASIA-PACIFIC ACUTE INTERMITTENT PORPHYRIA BY COUNTRIES

7.1 Asia-Pacific Acute Intermittent Porphyria Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Acute Intermittent Porphyria Sales and Market Share by Countries (2013-2018)
  7.1.2 Asia-Pacific Acute Intermittent Porphyria Revenue and Market Share by Countries (2013-2018)
7.2 China Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
7.3 Japan Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
7.4 Korea Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
7.5 India Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

8 SOUTH AMERICA ACUTE INTERMITTENT PORPHYRIA BY COUNTRIES

8.1 South America Acute Intermittent Porphyria Sales, Revenue and Market Share by Countries
  8.1.1 South America Acute Intermittent Porphyria Sales and Market Share by Countries (2013-2018)
  8.1.2 South America Acute Intermittent Porphyria Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
8.3 Argentina Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
8.4 Colombia Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA ACUTE INTERMITTENT PORPHYRIA BY COUNTRIES

9.1 Middle East and Africa Acute Intermittent Porphyria Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Acute Intermittent Porphyria Sales and Market Share by Countries (2013-2018)
  9.1.2 Middle East and Africa Acute Intermittent Porphyria Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
9.3 UAE Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
9.4 Egypt Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
9.5 Nigeria Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
9.6 South Africa Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)

10 GLOBAL ACUTE INTERMITTENT PORPHYRIA MARKET SEGMENT BY TYPE

10.1 Global Acute Intermittent Porphyria Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Acute Intermittent Porphyria Sales and Market Share by Type (2013-2018)
  10.1.2 Global Acute Intermittent Porphyria Revenue and Market Share by Type (2013-2018)
10.2 Gonadotropin-Releasing Hormone Analogues Sales Growth and Price
  10.2.1 Global Gonadotropin-Releasing Hormone Analogues Sales Growth (2013-2018)
  10.2.2 Global Gonadotropin-Releasing Hormone Analogues Price (2013-2018)
10.3 Prophylactic Hematin Infusions Sales Growth and Price
  10.3.1 Global Prophylactic Hematin Infusions Sales Growth (2013-2018)
  10.3.2 Global Prophylactic Hematin Infusions Price (2013-2018)

11 GLOBAL ACUTE INTERMITTENT PORPHYRIA MARKET SEGMENT BY APPLICATION

11.1 Global Acute Intermittent Porphyria Sales Market Share by Application (2013-2018)
11.2 Hospitals & Clinics Sales Growth (2013-2018)
11.3 Research Centers Sales Growth (2013-2018)

12 ACUTE INTERMITTENT PORPHYRIA MARKET FORECAST (2018-2023)

12.1 Global Acute Intermittent Porphyria Sales, Revenue and Growth Rate (2018-2023)
12.2 Acute Intermittent Porphyria Market Forecast by Regions (2018-2023)
  12.2.1 North America Acute Intermittent Porphyria Market Forecast (2018-2023)
  12.2.2 Europe Acute Intermittent Porphyria Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Acute Intermittent Porphyria Market Forecast (2018-2023)
  12.2.4 South America Acute Intermittent Porphyria Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Acute Intermittent Porphyria Market Forecast (2018-2023)
12.3 Acute Intermittent Porphyria Market Forecast by Type (2018-2023)
  12.3.1 Global Acute Intermittent Porphyria Sales Forecast by Type (2018-2023)
  12.3.2 Global Acute Intermittent Porphyria Market Share Forecast by Type (2018-2023)
12.4 Acute Intermittent Porphyria Market Forecast by Application (2018-2023)
  12.4.1 Global Acute Intermittent Porphyria Sales Forecast by Application (2018-2023)
  12.4.2 Global Acute Intermittent Porphyria Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Acute Intermittent Porphyria Picture
Table Product Specifications of Acute Intermittent Porphyria
Figure Global Sales Market Share of Acute Intermittent Porphyria by Types in 2017
Table Acute Intermittent Porphyria Types for Major Manufacturers
Figure Gonadotropin-Releasing Hormone Analogues Picture
Figure Prophylactic Hematin Infusions Picture
Figure Acute Intermittent Porphyria Sales Market Share by Applications in 2017
Figure Hospitals & Clinics Picture
Figure Research Centers Picture
Figure United States Acute Intermittent Porphyria Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Acute Intermittent Porphyria Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Acute Intermittent Porphyria Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Acute Intermittent Porphyria Revenue (Value) and Growth Rate (2013-2023)
Figure France Acute Intermittent Porphyria Revenue (Value) and Growth Rate (2013-2023)
Figure UK Acute Intermittent Porphyria Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Acute Intermittent Porphyria Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Acute Intermittent Porphyria Revenue (Value) and Growth Rate (2013-2023)
Figure China Acute Intermittent Porphyria Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Acute Intermittent Porphyria Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Acute Intermittent Porphyria Revenue (Value) and Growth Rate (2013-2023)
Figure India Acute Intermittent Porphyria Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Acute Intermittent Porphyria Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Acute Intermittent Porphyria Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Acute Intermittent Porphyria Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Acute Intermittent Porphyria Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Acute Intermittent Porphyria Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Acute Intermittent Porphyria Revenue (Value) and Growth Rate (2013-2023)
Table Dahaner Basic Information, Manufacturing Base and Competitors
Table Dahaner Acute Intermittent Porphyria Type and Applications
Table Dahaner Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Acute Intermittent Porphyria Type and Applications
Table Roche Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table Bio-Rad Laboratories Acute Intermittent Porphyria Type and Applications
Table Bio-Rad Laboratories Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Siemens Basic Information, Manufacturing Base and Competitors
Table Siemens Acute Intermittent Porphyria Type and Applications
Table Siemens Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ARKRAY Basic Information, Manufacturing Base and Competitors
Table ARKRAY Acute Intermittent Porphyria Type and Applications
Table ARKRAY Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table Sysmex Corporation Acute Intermittent Porphyria Type and Applications
Table Sysmex Corporation Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ACON Laboratories Basic Information, Manufacturing Base and Competitors
Table ACON Laboratories Acute Intermittent Porphyria Type and Applications
Table ACON Laboratories Acute Intermittent Porphyria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Acute Intermittent Porphyria Sales by Manufacturer (2016-2017)
Figure Global Acute Intermittent Porphyria Sales Market Share by Manufacturer in 2016
Figure Global Acute Intermittent Porphyria Sales Market Share by Manufacturer in 2017
Table Global Acute Intermittent Porphyria Revenue by Manufacturer (2016-2017)
Figure Global Acute Intermittent Porphyria Revenue Market Share by Manufacturer in 2016
Figure Global Acute Intermittent Porphyria Revenue Market Share by Manufacturer in 2017
Figure Top 3 Acute Intermittent Porphyria Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Acute Intermittent Porphyria Manufacturer (Revenue) Market Share in 2017
Figure Global Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure Global Acute Intermittent Porphyria Revenue and Growth Rate (2013-2018)
Table Global Acute Intermittent Porphyria Sales by Regions (2013-2018)
Table Global Acute Intermittent Porphyria Sales Market Share by Regions (2013-2018)
Table Global Acute Intermittent Porphyria Revenue by Regions (2013-2018)
Figure Global Acute Intermittent Porphyria Revenue Market Share by Regions in 2013
Figure Global Acute Intermittent Porphyria Revenue Market Share by Regions in 2017
Figure North America Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure Europe Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure South America Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure North America Acute Intermittent Porphyria Revenue and Growth Rate (2013-2018)
Table North America Acute Intermittent Porphyria Sales by Countries (2013-2018)
Table North America Acute Intermittent Porphyria Sales Market Share by Countries (2013-2018)
Figure North America Acute Intermittent Porphyria Sales Market Share by Countries in 2013
Figure North America Acute Intermittent Porphyria Sales Market Share by Countries in 2017
Table North America Acute Intermittent Porphyria Revenue by Countries (2013-2018)
Table North America Acute Intermittent Porphyria Revenue Market Share by Countries (2013-2018)
Figure North America Acute Intermittent Porphyria Revenue Market Share by Countries in 2013
Figure North America Acute Intermittent Porphyria Revenue Market Share by Countries in 2017
Figure United States Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure Canada Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure Mexico Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure Europe Acute Intermittent Porphyria Revenue and Growth Rate (2013-2018)
Table Europe Acute Intermittent Porphyria Sales by Countries (2013-2018)
Table Europe Acute Intermittent Porphyria Sales Market Share by Countries (2013-2018)
Table Europe Acute Intermittent Porphyria Revenue by Countries (2013-2018)
Figure Europe Acute Intermittent Porphyria Revenue Market Share by Countries in 2016
Figure Europe Acute Intermittent Porphyria Revenue Market Share by Countries in 2017
Figure Germany Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure UK Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure France Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure Russia Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure Italy Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Acute Intermittent Porphyria Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Acute Intermittent Porphyria Sales by Countries (2013-2018)
Table Asia-Pacific Acute Intermittent Porphyria Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Acute Intermittent Porphyria Sales Market Share by Countries 2017
Table Asia-Pacific Acute Intermittent Porphyria Revenue by Countries (2013-2018)
Figure Asia-Pacific Acute Intermittent Porphyria Revenue Market Share by Countries 2017
Figure China Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure Japan Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure Korea Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure India Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure Southeast Asia Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure South America Acute Intermittent Porphyria Revenue and Growth Rate (2013-2018)
Table South America Acute Intermittent Porphyria Sales by Countries (2013-2018)
Table South America Acute Intermittent Porphyria Sales Market Share by Countries (2013-2018)
Figure South America Acute Intermittent Porphyria Sales Market Share by Countries in 2017
Table South America Acute Intermittent Porphyria Revenue by Countries (2013-2018)
Table South America Acute Intermittent Porphyria Revenue Market Share by Countries (2013-2018)
Figure South America Acute Intermittent Porphyria Revenue Market Share by Countries in 2017
Figure Brazil Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure Argentina Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure Colombia Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Acute Intermittent Porphyria Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Acute Intermittent Porphyria Sales by Countries (2013-2018)
Table Middle East and Africa Acute Intermittent Porphyria Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Acute Intermittent Porphyria Sales Market Share by Countries in 2017
Table Middle East and Africa Acute Intermittent Porphyria Revenue by Countries (2013-2018)
Table Middle East and Africa Acute Intermittent Porphyria Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Acute Intermittent Porphyria Revenue Market Share by Countries in 2013
Figure Middle East and Africa Acute Intermittent Porphyria Revenue Market Share by Countries in 2017
Figure Saudi Arabia Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure UAE Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure Egypt Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure Nigeria Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Figure South Africa Acute Intermittent Porphyria Sales and Growth Rate (2013-2018)
Table Global Acute Intermittent Porphyria Sales by Type (2013-2018)
Table Global Acute Intermittent Porphyria Sales Share by Type (2013-2018)
Table Global Acute Intermittent Porphyria Revenue by Type (2013-2018)
Table Global Acute Intermittent Porphyria Revenue Share by Type (2013-2018)
Figure Global Gonadotropin-Releasing Hormone Analogues Sales Growth (2013-2018)
Figure Global Gonadotropin-Releasing Hormone Analogues Price (2013-2018)
Figure Global Prophylactic Hematin Infusions Sales Growth (2013-2018)
Figure Global Prophylactic Hematin Infusions Price (2013-2018)
Table Global Acute Intermittent Porphyria Sales by Application (2013-2018)
Table Global Acute Intermittent Porphyria Sales Share by Application (2013-2018)
Figure Global Research Centers Sales Growth (2013-2018)
Figure Global Acute Intermittent Porphyria Sales, Revenue and Growth Rate (2018-2023)
Table Global Acute Intermittent Porphyria Sales Forecast by Regions (2018-2023)
Table Global Acute Intermittent Porphyria Market Share Forecast by Regions (2018-2023)
Figure North America Sales Acute Intermittent Porphyria Market Forecast (2018-2023)
Figure Europe Sales Acute Intermittent Porphyria Market Forecast (2018-2023)
Figure Asia-Pacific Sales Acute Intermittent Porphyria Market Forecast (2018-2023)
Figure South America Sales Acute Intermittent Porphyria Market Forecast (2018-2023)
Figure Middle East and Africa Sales Acute Intermittent Porphyria Market Forecast (2018-2023)
Table Global Acute Intermittent Porphyria Sales Forecast by Type (2018-2023)
Table Global Acute Intermittent Porphyria Market Share Forecast by Type (2018-2023)
Table Global Acute Intermittent Porphyria Sales Forecast by Application (2018-2023)
Table Global Acute Intermittent Porphyria Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List